Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells

This publication has 31 references indexed in Scilit:

• A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains
  FEBS Letters, 2002
• Regulation of NMDA receptors by cyclin-dependent kinase-5
  Proceedings of the National Academy of Sciences, 2001
• Regulation of N-cadherin-mediated adhesion by the p35–Cdk5 kinase
  Current Biology, 2000
• Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
  Nature, 1999
• The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity
  Nature, 1998
• Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
  Proceedings of the National Academy of Sciences, 1996
• The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
  Genes & Development, 1996
• p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
  Nature, 1994
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
  Proceedings of the National Academy of Sciences, 1986
• Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.
  Proceedings of the National Academy of Sciences, 1986